◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
天康生物 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
+Revenue 17.2B 19.0B 17.0B 15.7B 12.0B
Revenue Growth % -9.7% 12.0% 8.1% 31.1% --
Total Revenue 17.2B 19.0B 17.0B 15.7B 12.0B
Cost Of Revenue 15.1B 18.5B 15.3B 14.2B 8.6B
+Gross Profit 2.1B 557.0M 1.7B 1.5B 3.4B
Gross Margin % 12.1% 2.9% 10.1% 9.6% 28.3%
Total Operating Cost 16.6B 20.5B 16.8B 16.4B 10.2B
Selling Expenses 428.0M 543.0M 493.0M 507.0M 376.0M
Admin Expenses 560.0M 487.0M 478.0M 831.0M 900.0M
Rd Expenses 200.0M 257.0M 179.0M 171.0M 104.0M
Finance Expenses 155.0M 192.0M 203.0M 192.0M 179.0M
+Operating Income 631.0M -1.4B 257.0M -617.0M 1.8B
Operating Margin % 3.7% -7.6% 1.5% -3.9% 15.1%
Non Operating Income 30.1M 2.8M 1.7M 3.9M 2.9M
Non Operating Expenses 50.4M 49.7M 42.5M 50.5M 3.3M
Investment Income -1.9M 3.5M 16.9M 30.9M 29.6M
Fair Value Change Income 50,900 -3,500 939,500 -- -778,500
Asset Disposal Income 4.5M 3.9M 227,300 -36.7M -60.3M
Asset Impairment Loss 22.7M 500.0M 107.0M 385.0M --
Other Income 64.3M 69.4M 64.2M 34.9M 46.7M
Income Before Tax 611.0M -1.5B 216.0M -663.0M 1.8B
Income Tax 14.4M 23.5M 26.0M 31.9M 22.4M
+Net Income 596.0M -1.5B 190.0M -695.0M 1.8B
Net Margin % 3.5% -8.0% 1.1% -4.4% 14.9%
Net Income Attributable 605.0M -1.4B 281.0M -703.0M 1.7B
Minority Interest -8.6M -153.0M -90.8M 7.4M 64.9M
Eps Basic 0.44 -1.01 0.21 -0.64 1.61
Eps Diluted 0.44 -1.01 0.21 -0.63 1.60
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash And Equivalents 3.1B 2.8B 3.3B 3.4B 2.1B
Trading Financial Assets 5.5M 473,100 651.0M -- 20.3M
Accounts Receivable 469.0M 421.0M 388.0M 306.0M 320.0M
Notes Receivable 64.6M 9.6M 10.9M 8.4M 7.3M
Notes And Accounts Receivable 534.0M 431.0M 399.0M 314.0M 327.0M
Prepayments 837.0M 387.0M 1.1B 796.0M 1.6B
Inventory 4.6B 4.6B 6.0B 5.3B 6.0B
Total Current Assets 9.8B 9.0B 12.4B 10.6B 10.7B
Long Term Equity Investment 33.3M 36.1M 105.0M 108.0M 105.0M
Fixed Assets -- 5.3B 5.1B 4.3B 3.7B
Fixed Assets Total 5.9B 5.3B 5.1B 4.3B 3.7B
Construction In Progress -- 815.0M 425.0M 895.0M 539.0M
Construction In Progress Total 233.0M 815.0M 425.0M 895.0M 539.0M
Intangible Assets 377.0M 361.0M 268.0M 272.0M 233.0M
Long Term Deferred Expenses 19.3M 24.0M 23.1M 26.2M 95.7M
Total Non Current Assets 7.7B 7.8B 7.0B 6.5B 5.0B
Total Assets 17.6B 16.8B 19.4B 17.1B 15.7B
Short Term Borrowings 3.2B 3.3B 3.2B 4.0B 4.8B
Accounts Payable 601.0M 692.0M 611.0M 465.0M 422.0M
Advance Receipts 357,100 48,500 83,300 473,300 --
Contract Liabilities 666.0M 440.0M 472.0M 681.0M 601.0M
Total Current Liabilities 6.5B 7.1B 6.2B 7.0B 7.4B
Long Term Borrowings 2.1B 1.2B 3.1B 2.0B 1.3B
Total Non Current Liabilities 2.5B 1.8B 3.5B 2.4B 1.5B
Total Liabilities 9.0B 8.8B 9.7B 9.4B 8.9B
Paid In Capital 1.4B 1.4B 1.4B 1.4B 1.1B
Capital Reserve 3.9B 3.9B 3.8B 3.3B 1.5B
Surplus Reserve 467.0M 467.0M 439.0M 275.0M 227.0M
Retained Earnings 1.2B 581.0M 2.3B 2.2B 3.5B
Minority Equity 1.5B 1.5B 1.7B 635.0M 634.0M
Equity Attributable 7.0B 6.4B 7.9B 7.1B 6.2B
Total Equity 8.5B 7.9B 9.6B 7.7B 6.9B
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash From Sales 18.4B 19.8B 17.2B 16.4B 12.4B
Tax Refunds Received 186,600 55.2M -- -- --
Total Operating Cash Inflow 18.7B 20.1B 17.4B 16.5B 12.5B
Cash Paid For Goods 15.9B 16.6B 15.4B 13.0B 12.1B
Cash Paid To Employees 922.0M 956.0M 896.0M 980.0M 654.0M
Taxes Paid 192.0M 166.0M 215.0M 122.0M 120.0M
Total Operating Cash Outflow 17.6B 18.3B 17.1B 15.0B 13.1B
Operating Cash Flow 1.2B 1.8B 328.0M 1.5B -601.0M
Total Investing Cash Inflow 55.4M 899.0M 158.0M 159.0M 409.0M
Total Investing Cash Outflow 805.0M 1.7B 2.2B 1.9B 1.2B
Investing Cash Flow -750.0M -775.0M -2.1B -1.8B -806.0M
Cash From Borrowings 6.8B 4.9B 5.0B 5.9B 5.3B
Dividends And Interest Paid 208.0M 592.0M 261.0M 702.0M 404.0M
Debt Repayments 6.7B 5.9B 4.7B 5.6B 3.5B
Total Financing Cash Inflow 6.9B 5.0B 6.6B 7.9B 5.4B
Total Financing Cash Outflow 7.0B 6.5B 5.0B 6.3B 3.9B
Financing Cash Flow -131.0M -1.5B 1.6B 1.6B 1.5B
Net Change In Cash 281.0M -528.0M -111.0M 1.4B 92.8M
Ending Cash Balance 3.0B 2.7B 3.2B 3.3B 1.9B
Capex 626.0M 1.0B 1.4B 1.8B 930.0M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...